|
Volumn 18, Issue 10, 2005, Pages 1507-1511
|
Letters to the editor
a b b c d |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACYLTRANSFERASE;
CARCINOGEN;
DNA;
HYDROXYSTEROID SULFOTRANSFERASE;
HYDROXYTAMOXIFEN;
NORTAMOXIFEN;
NUCLEOTIDE;
PHOSPHATASE;
PHOSPHORUS 32;
TAMOXIFEN;
ALPHA HYDROXYTAMOXIFEN;
ALPHA-HYDROXYTAMOXIFEN;
DRUG DERIVATIVE;
MUTAGENIC AGENT;
ACETYLATION;
BREAST CANCER;
CHEMOLUMINESCENCE;
DNA ADDUCT;
DRUG BLOOD LEVEL;
ELECTROSPRAY MASS SPECTROMETRY;
ENDOMETRIUM;
ENDOMETRIUM CANCER;
GENOTOXICITY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LETTER;
LIQUID CHROMATOGRAPHY;
SULFATION;
TANDEM MASS SPECTROMETRY;
THIN LAYER CHROMATOGRAPHY;
BIOSYNTHESIS;
CELL CULTURE;
DOSE RESPONSE;
DRUG EFFECT;
FEMALE;
METABOLISM;
NOTE;
CELLS, CULTURED;
DNA ADDUCTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOMETRIUM;
FEMALE;
HUMANS;
MUTAGENS;
TAMOXIFEN;
|
EID: 27144503005
PISSN: 0893228X
EISSN: None
Source Type: Journal
DOI: 10.1021/tx050246n Document Type: Letter |
Times cited : (8)
|
References (0)
|